The future of psoriasis treatment is likely to be based on clinical, genetic and immune biomarkers that will individualize treatment and may potentially optimize disease outcome.
Wolfram Sterry, Juliet N. Barker, Wolf‐Henning Boehncke, J.D. Bos, Sergio Chimenti, Enno Christophers, M. de la Brassinne, Christopher Em Griffiths, Andreas Katsambas, Knud Kragballe, Charles Lynde, Alan Menter, J.‐P. Ortonne, Kim Papp, Jörg C. Prinz, Berthold Rzany, J.R. Rönnevig, J.‐H. Saurat, Mona Ståhle, Fernando Stengel, P.C.M. van de Kerkhof, John J. Voorhees
Sophia Quirke‐McFarlane, John Weinman, Emma Cook, Zenas Z N Yiu, Nick Dand, Sinéad Langan, Katie Bechman, Teresa Tsakok, K.J. Mason, Helen McAteer, Freya Meynell, Bolaji Coker, Alexandra Vincent, Dominic Urmston, A Vesty, J Kelly, Camille Lancelot, Lucy Moorhead, Inês A. Barbosa, H. Bachelez, Francesca Capon, Claudia Romina Contreras, C. Cruz,
.webp)
Discussion(0)
No comments yet. Be the first to comment.